Merck Suspends Gardasil Sales in China, Influencing 2025 Financial Projections
2 months ago
In a significant move that has sent ripples through the pharmaceutical industry, Merck & Co. has announced the cessation of sales for its Gardasil vaccine in China. This decision has far-reaching implications for the company's financial outlook for 2025, as China has been a pivotal market for the HPV vaccine.
Continue reading
Merck Adjusts Sales Forecast Amid Slowing Demand for Gardasil Vaccine in China
5 months ago
In a recent update, Merck & Co. has revised its sales outlook downward, largely attributed to subpar demand for its Gardasil vaccine in the Chinese market. The pharmaceutical giant is now bracing for a potential decline in sales as the uptake of their human papillomavirus (HPV) vaccine fails to meet projections.
Continue reading